Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Download search results Subscribe to news feed Your filters: cql: author=" Hillmen, Peter" or (type any "bookEditor journalEditor issueEditor" and editor=" Hillmen... Add to list Miscellaneous open access Many people with chronic lymphocytic leukemia or small lymphocytic lymphoma benefit from Ibrutinib treatment up to 8 years : a plain language summary Paul M. Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan A. Burger, Peter Hillmen, Claire Dearden, Sebastian Grosicki, Helen McCarthy, et al. (2022) FUTURE ONCOLOGY. 18(37). p.4047-4057 Add to list Journal Article A1 open access Up to 8-year follow-up from RESONATE-2 : first-line ibrutinib treatment for patients with chronic lymphocytic leukemia Paul M. Barr, Carolyn Owen, Tadeusz Robak, Alessandra Tedeschi, Osnat Bairey, Jan A. Burger, Peter Hillmen, Steve E. Coutre, Claire Dearden, Sebastian Grosicki, et al. (2022) BLOOD ADVANCES. 6(11). p.3440-3450